Skip to content
healthcare.dev

ROFLUMILAST

NDC 42571-369, ROFLUMILAST, tablet, from Micro Labs Limited.

Product NDC
42571-369
Status
Listed
Labeler
Micro Labs Limited
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA208180
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/42571-369 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ROFLUMILAST250 ug/1

Pharmacologic classes

Phosphodiesterase 4 Inhibitor [EPC]; Phosphodiesterase 4 Inhibitors [MoA]

Package NDCNDC-11Package
42571-369-0542571036905500 TABLET in 1 BOTTLE (42571-369-05)
42571-369-114257103691110 BLISTER PACK in 1 CARTON (42571-369-11) / 10 TABLET in 1 BLISTER PACK (42571-369-32)
42571-369-304257103693030 TABLET in 1 BOTTLE (42571-369-30)
42571-369-834257103698328 TABLET in 1 BOTTLE (42571-369-83)
42571-369-904257103699090 TABLET in 1 BOTTLE (42571-369-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/dc2a689f-cfa4-4863-9623-a9813dcf86a9
  • NADAC price for package 42571036983

    GET /v1/drugs/nadac/42571036983

Use it

Look up 42571-369 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/42571-369 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 42571-369. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.